Blood−brain barrier transporters and response to CNS-active drugs Bradley L. UrquhartRichard B. Kim Review Article 02 September 2009 Pages: 1063 - 1070
Statins and total (not LDL) cholesterol concentration and outcome of myocardial infarction: results from a meta-analysis and an observational study Xia ShengLi WeiThomas M. MacDonald Review Article 03 September 2009 Pages: 1071 - 1080
Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors Todd HulganJohn P. DonahueThe AIDS Clinical Trials Group Study A5138 Team Clinical Trial 25 September 2009 Pages: 1081 - 1088
Nurse-led medication reviews and the quality of drug treatment of elderly hospitalized patients Monica BergqvistJohanna UlfvarsonEva Andersén Karlsson Clinical Trial 02 October 2009 Pages: 1089 - 1096
Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients Masako OhnoAkiko YamamotoJunichi Azuma Pharmacogenetics 07 July 2009 Pages: 1097 - 1103
The development of an objective methodology to measure medication adherence to oral thiopurines in paediatric patients with acute lymphoblastic leukaemia—an exploratory study Ahmed F. HawwaJeff S. MillershipJames C. McElnay Pharmacokinetics and Disposition 28 July 2009 Pages: 1105 - 1112
Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: a transnational study Richard HallinanSéverine CrettolChin B. Eap Pharmacokinetics and Disposition 29 July 2009 Pages: 1113 - 1120
Population pharmacokinetics of recombinant factor VIII:C (ReFacto®) in adult HIV-negative and HIV-positive haemophilia patients Anastasia KarafoulidouElena SuarezJohn C. Lukas Pharmacokinetics and Disposition 30 July 2009 Pages: 1121 - 1130
Antidepressants and cardiovascular outcomes in patients without known cardiovascular risk Simona MonteAlejandro MacchiaGianni Tognoni Pharmacoepidemiology and Prescription 14 July 2009 Pages: 1131 - 1138
The use of driving impairing medicines: a European survey Silvia RaveraSylvia A. HummelJohan J. de Gier Pharmacoepidemiology and Prescription Open access 21 July 2009 Pages: 1139 - 1147
Successful strategy to improve the specificity of electronic statin–drug interaction alerts Hanna Marita SeidlingCaroline Henrike StorchWalter Emil Haefeli Pharmacoepidemiology and Prescription 30 July 2009 Pages: 1149 - 1157
Individualized dosing of aminoglycosides in neonates: mission accomplished or work in progress? John N. van den AnkerKarel Allegaert Letter to the Editors Open access 07 July 2009 Pages: 1159 - 1160
Prognostic value of the quality indicator “concurrent use of three or more psychotropic drugs” among residents of long-term care facilities: a comment Eva LesénMax PetzoldAnders Carlsten Letter to the Editors 10 July 2009 Pages: 1161 - 1161
Prognostic value of the quality indicator “concurrent use of three or more psychotropic drugs” among residents of long-term-care facilities J. Simon BellHeidi T. TaipaleKaisu H. Pitkälä Letter to the Editors 14 July 2009 Pages: 1163 - 1164
Seretide withdrawal increases airway inflammation in moderate COPD patients Zoe BorrillKay RoyDave Singh Letter to the Editors 15 July 2009 Pages: 1165 - 1166
Protopathic bias in observational studies on statin effectiveness Maarit Jaana KorhonenRisto HuupponenArja Helin-Salmivaara Letter to the Editors 22 July 2009 Pages: 1167 - 1168